Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Ethyl p-(2-oxo-1,3-oxazolidin-3-yl)benzoate → 3-{4-[4-(2,6-Dimethylpyridin-3-yl)piperazine-1-carbonyl]phenyl}oxazolidin-2-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Ethyl p-(2-oxo-1,3-oxazolidin-3-yl)benzoate | HCID 616604 | — |
| 반응물 | 1-(2,6-Dimethylpyridin-3-yl)piperazine | HCID 58484703 | — |
| 생성물 | 3-{4-[4-(2,6-Dimethylpyridin-3-yl)piperazine-1-carbonyl]phenyl}oxazolidin-2-one | HCID 58484811 | 15.8% |
반응 단계
By reaction and treatment in the same manner as in Example 34 and using ethyl 4-(2-oxooxazolidin-3-yl)benzoate (353 mg) described in Preparation Example 12 and 1-(2,6-dimethylpyridin-3-yl)piperazine (287 mg) described in Preparation Example 153, the title compound (90.2 mg) was obtained.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US08354401B2 |
| 출처 데이터셋 | uspto-grants-2013_01 |
| ORD ID | ord-2f016fdd0c174f72b85a00e4faed29d4 |
| 출처 메모 | uspto-grants-2013_01 |